WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, June 17, 2009, 29(24):7820-7832; doi:10.1523/JNEUROSCI.0932-09.2009

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Wilkinson, M. B.
Right arrow Articles by Nestler, E. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilkinson, M. B.
Right arrow Articles by Nestler, E. J.

 Previous Article  |  Next Article 

Neurobiology of Disease
Imipramine Treatment and Resiliency Exhibit Similar Chromatin Regulation in the Mouse Nucleus Accumbens in Depression Models

Matthew B. Wilkinson,1 * Guanghua Xiao,2 * Arvind Kumar,3 * Quincey LaPlant,1 William Renthal,2 Devanjan Sikder,4 Thomas J. Kodadek,4 and Eric J. Nestler1

1Fishberg Department of Neuroscience, Mount Sinai School of Medicine, New York, New York 10029-6574, 2Departments of Clinical Sciences, 3Psychiatry, and 4Internal Medicine and Division of Translational Research, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390

Correspondence should be addressed to Eric J. Nestler, One Gustave L. Levy Place, Box 1065, New York, NY 10029-6574. Email: eric.nestler{at}mssm.edu

Although it is a widely studied psychiatric syndrome, major depressive disorder remains a poorly understood illness, especially with regard to the disconnect between treatment initiation and the delayed onset of clinical improvement. We have recently validated chronic social defeat stress in mice as a model in which a depression-like phenotype is reversed by chronic, but not acute, antidepressant administration. Here, we use chromatin immunoprecipitation (ChIP)-chip assays—ChIP followed by genome wide promoter array analyses—to study the effects of chronic defeat stress on chromatin regulation in the mouse nucleus accumbens (NAc), a key brain reward region implicated in depression. Our results demonstrate that chronic defeat stress causes widespread and long-lasting changes in gene regulation, including alterations in repressive histone methylation and in phospho-CREB (cAMP response element-binding protein) binding, in the NAc. We then show similarities and differences in this regulation to that observed in another mouse model of depression, prolonged adult social isolation. In the social defeat model, we observed further that many of the stress-induced changes in gene expression are reversed by chronic imipramine treatment, and that resilient mice—those resistant to the deleterious effects of defeat stress—show patterns of chromatin regulation in the NAc that overlap dramatically with those seen with imipramine treatment. These findings provide new insight into the molecular basis of depression-like symptoms and the mechanisms by which antidepressants exert their delayed clinical efficacy. They also raise the novel idea that certain individuals resistant to stress may naturally mount antidepressant-like adaptations in response to chronic stress.


Received Feb. 24, 2009; revised May 5, 2009; accepted May 6, 2009.

Correspondence should be addressed to Eric J. Nestler, One Gustave L. Levy Place, Box 1065, New York, NY 10029-6574. Email: eric.nestler{at}mssm.edu






-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-